Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samir Asher
Observed name:
S. Asher
Institutions:
University College London Hospitals NHS Foundation Trust,
University College London
Observed institutions:
University College Hospital,
Guy's Hospital,
University College London Hospitals NHS Foundation Trust,
Guy's and St Thomas' NHS Foundation Trust,
National Institute for Health and Care Research,
St Mary's Hospital,
Lewisham and Greenwich NHS Trust,
University College London
show all 8
ORCID:
0000-0002-7846-9437
Observed ORCID:
0000-0002-7846-9437
OpenAlex ID:
A5013613031
Current and future therapies for myelofibrosis
2020
·
Samir Asher
, Donal P. McLornan
, et al.
·
Blood Reviews
·
23
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
2022
·
Kara-Louise Royle
, Amy Beth Coulson
, et al.
·
BMJ Open
·
19
PDF
Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma
2022
·
Samir Asher
, Aikaterini Kazantzi
, et al.
·
Haematologica
·
12
PDF
Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation
2022
·
Kwee Yong
, Kara-Louise Royle
, et al.
·
Blood
·
7
First-in-human phase I study of a ROR1-targeting bispecific T-cell engager (NVG-111) shows evidence of efficacy in patients with relapsed/refractory CLL and MCL.
2022
·
Parag Jasani
, William Townsend
, et al.
·
Journal of Clinical Oncology
·
7
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience
2024
·
Dario Melotti
, Samir Asher
, et al.
·
eJHaem
·
4
PDF
Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR study
2025
·
Dipal Mehta
, Robert Cicero
, et al.
·
eJHaem
·
2
PDF
Belantamab Mafodotin Monotherapy for Multiply‐Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of Ireland
2025
·
Edmund C. R. Watson
, Faouzi Djebbari
, et al.
·
eJHaem
·
2
PDF
Haematopoietic stem cell mobilisation followed by high‐dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma
2023
·
S. Asher
, R. Shah
, et al.
·
British Journal of Haematology
·
1
Myeloma and MGUS
2021
·
Samir Asher
, Matthew J. Streetly
·
Medicine
·
1
Effective Targeting of Evolutions in Concerns Underpinning COVID Vaccine Hesitancy in Patients with Sickle Cell Disease across the Lifespan of the COVID19 Pandemic
2023
·
Sarah Helen Oram
, Shwe Ei
, et al.
·
Blood
PDF
P-322 Real world outcomes of belantamab mafodotin from the UK and Ireland: updated results
2023
·
Edmund Watson
, Faouzi Djebbari
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P-479 Disparities in clinical trial enrolment and survival outcomes by socio-economic class in multiple myeloma
2023
·
Amrutha Sridhar
, Selina Chavda
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Pb2091: Disparities in Enrolment Into Multiple Myeloma Clinical Trials by Socioeconomic Deprivation
2023
·
Amrutha Sridhar
, Selina Chavda
, et al.
·
HemaSphere
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience
2023
·
George Nesr
, Raakhee Shah
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
PDF
P-206: Antibodies to omicron variants are maintained in newly diagnosed MM patients on lenalidomide, cyclophosphamide, bortezomib and dexamethasone (RCyBorD): results from the UK RADAR/Myeloma XV Trial
2022
·
Samir Asher
, Sian Faustini
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AL amyloidosis
2021
·
Samir Asher
, Majid Kazmi
·
Medicine
FRI0180 Do Shared Care Schemes Work for Methotrexate Monitoring?
2014
·
G.S. Dulay
, S. Asher
·
Annals of the Rheumatic Diseases
Show more works
View as search
Works count:
18
Citation count:
78
H-index:
5
I10-index:
3
Year
Topic
Type